₹ 2.63
0.11 (4.37%)
BSE
T
Transgene Biotek
₹ 2.63
BSE
TRABI Financials Summary (Consolidated)
Transgene Biotek revenue decreased 50.00% quarter-on-quarter to ₹0 Cr in Jun 2026, while net loss narrowed to ₹0 Cr from ₹1 Cr in the previous quarter. Compared to the same quarter last year, revenue was largely unchanged and net loss widened to ₹0 Cr from ₹0 Cr a year ago. EPS for the quarter stood at -₹0.05, increased from -₹0.06 in the previous quarter and up from -₹0.06 a year ago.
Transgene Biotek Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of TRABI Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
TRABI Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






